Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIAA1958 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | BHLHE41 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | CELF2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | RNF182 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | RP11-724O16.1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | ABI3BP | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | AVPI1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | NABP1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | ZBTB38 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | PLA2G4C | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |